logo

For the Inventor, By the Inventor

Kawasaki, Japan

Manabu Suzuki

This inventor holds 24 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents, primarily in Biotechnology. Top assignees: Ajinomoto Co., Ltd., Fujitsu Corporation, Morinaga Milk Industry Co., Ltd.. Active years: 1996-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Manabu Suzuki. Retrieved from https://idiyas.com/inventor/manabu-suzuki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24

% Patents Active = 41.7



Average Co-Inventor Count = 6.3

ph-index = 7

Forward Citations = 178(Granted Patents)


Location History:

  • Kawasaki, JP (1996 - 2011)
  • Kanagawa, JP (2006 - 2011)
  • Chuo-ku, JP (2012)
  • Zama, JP (2018)

Company Filing History:

goldMedal16 out of 1,953 
 
Ajinomoto Co., Ltd.
 patents
silverMedal4 out of 39,374 
 
Fujitsu Corporation
 patents
bronzeMedal2 out of 185 
 
Morinaga Milk Industry Co., Ltd.
 patents
4. 1 out of 2 
 
Kazuo Sugamura
 patents
5. 6 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1996-2018

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Denatured Whey Protein
Inflammatory Bowel Disease
Anti-Tumor Composition
Heterocyclic Compounds
Wavelength Division Multiplex
Peptide Inducing Immune Response
Human Gastric Cancer
Phenylalanine Derivatives
Optical Transmission
Image Processing
Medicinal Compositions
Human IL-2 Receptor
24 patents (USPTO):Explore Patents
1. 10080377 - Method for manufacturing denatured whey protein (2018-09-25),
2. 8168669 - Therapeutic agent for inflammatory bowel disease and TNF-α production inhibitor (2012-05-01),
3. 7973076 - Anti-tumor composition (2011-07-05),
4. 7902179 - Heterocyclic compounds (2011-03-08),
5. 7655696 - Anti-tumor composition (2010-02-02),
6. 7315696 - Gain setting method in wavelength division multiplex transmission equipment (2008-01-01),
7. 7279484 - Heterocyclic compounds (2007-10-09),
8. 7259754 - Pen sensor coordinate narrowing method and apparatus (2007-08-21),
9. 7160874 - Phenylalanine derivatives (2007-01-09),
10. 7153537 - Acidic drinks containing tofu puree (2006-12-26),
11. 7065297 - Optical transmission system (2006-06-20),
12. 7030222 - Human gastric cancer antigen gene and gastric cancer antigen protein (2006-04-18),
13. 6992106 - Anti-tumor composition (2006-01-31),
14. 6855706 - Phenylalanine derivatives (2005-02-15),
15. 6633283 - Image processing device and image processing method (2003-10-14),

Title: The Innovative Legacy of Manabu Suzuki: Pushing Boundaries in Invention.

Introduction: Manabu Suzuki, an esteemed inventor hailing from Kawasaki, Japan, has left an indelible mark on the world of technology with his groundbreaking patents and unwavering commitment to innovation.

Latest Patents: Among Manabu Suzuki's 24 patents, his recent inventions include a method for manufacturing denatured whey protein, aimed at producing high-quality protein without compromising product characteristics, and a therapeutic agent for inflammatory bowel disease and TNF-α production inhibitor, offering new possibilities in healthcare.

Career Highlights: Suzuki's career is adorned with achievements at leading companies like Ajinomoto Co., Ltd. His expertise in biochemistry and pharmaceuticals has led to significant advancements in the field, demonstrating his versatile skill set and passion for research and development.

Collaborations: Throughout his career, Manabu Suzuki has collaborated closely with esteemed coworkers such as Junji Hamuro and Yasuhiro Tanaka. Their collective efforts have resulted in innovative solutions that have reshaped industries and improved lives.

Conclusion: In conclusion, Manabu Suzuki's dedication to pushing the boundaries of innovation and his relentless pursuit of excellence continue to inspire inventors and entrepreneurs globally. His impact on the world of technology is truly remarkable, and his legacy as an inventor is set to endure for generations to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…